UT Virtual View Book
UT Rockets
A University Rising
UTMC Named Regions #1 Hospital
The Center for Neurological Health - Parkinson's Disease and Movement Disorders Program
|
Faculty: Mary (Molly) Scott, CNP Kim Cole, DNP, MSN, RN, FNP-BC
Aim: Diagnosis and treatment of movement disorders including Parkinson's and Huntington's Diseases, Essential and Familial Tremor, Tourette's Syndrome, Parkinsonian Syndromes and Dystonic Disorders. |
 |
Highlights:
Participation in multi-center clinical trials for the treatment of Parkinson's Disease;
surgical treatment of essential tremor and Parkinson's; implementation of the latest
pharmacological and surgical treatments for a variety of movement disorders.
Treatment Advances:
The Parkinson's Disease Movement Disorders Program (PDMDP) director has participated
in major clinical trials for the treatment of Parkinson's disease (PD) including trials
of neuroprotective and novel therapeutic agents. Recent advances in medical management
of early Parkinson's include once-daily therapies. Newly released and investigational
agents offer significant treatment options for patients experiencing limited response
to their current medications. For those patients inadequately treated with pharmacological
therapies, surgically effective treatment for tremors and Parkinson’s disease may
be available through the use of Deep Brain Stimulation. Finally, intramuscular injection
of botulinum toxin has demonstrated proven effectiveness for the treatment of dystonic
disorders including torticollis, focal dystonia, and blepharospasm.
Research:
Through involvement with the Parkinson's Study Group, industry and NIH sponsored multi-center
trials, the PDMDP participates in clinical trials of pharmacological agents for the
treatment of PD and long term complications of this disease. The molecular basis
of neurodegenerative disorders including Parkinson's and Huntington's Diseases are
also being examined through collaborative efforts with basic science research laboratories
on the University of Toledo Main and Health Science Campuses.
Fellowship:
The PDMDP also offers a Movement Disorders Fellowship to individuals who have completed
either Neurology or Psychiatry Residency Programs. The fellowship is designed for
either one or two years. In the first year, fellows are intensively exposed to the
diagnosis and management of hypo- and hyperkinetic movement disorders, including pharmacological
management of motor, behavioral and cognitive aspects of various movement disorders, including
the use of botulinum toxin for dystonias and deep brain stimulation for the treatment
of tremors or PD. If desired, fellows can participate for a second year, during which
time they serve as sub-investigators in clinical trails in PD (or HD as they become
available), in order to establish themselves as clinical trial investigators. During
the second year, fellows also have the option of pursuing basic science research in
the pathophysiology and treatment of movement disorders as well, either at UT or at
one of numerous nearby institutions.
Collaborations:
Neurology, Neurosurgery, Nursing, Neuroradiology, Neuropathology, Neuropsychology, Geriatric Psychiatry, and Rehabilitation Services.
__________________________________________________________________
 |
The Center for Neurological Health Movement Program recently was featured on University Health Matters. |
